Fortis Hospital Bannerghatta Road successfully treated a 25-year-old African woman who had been suffering from complex and ...

Possible causes include anxiety, fever, exercise, and an overactive thyroid gland. Though most causes of a bounding pulse are ...

EW saw its stock trading at around $95 in June 2022, just before the Fed started increasing rates, and it’s still trading 30% ...

Morgom, M. , Anjum, S. , Awadelseed, S. , Alajard, H. and Bakhiet, Y. (2024) Beyond the Usual Suspects (Aortic Dissection in ...

The field of interventional cardiology continues to rapidly evolve, reshaping the future of heart disease treatment.

Mitral valve regurgitation is the most common heart valve disease affecting up to 10% of the general population. It is also the second most common indication for heart valve surgery behind aortic ...

The company said the cuts to its global workforce are a “one-size right-sizing of the organization”. Edwards Lifesciences said it will lay off 3% of its global workforce in a “one-time right-sizing of ...

In Europe, incidences of severe native valvular heart disease (VHD) and their treatment vary between men and women. This is ...

Edwards Lifesciences (NYSE: EW), a medical technology company specializing in artificial heart valves, currently trades at $67 per share, about 50% lower than the peak level of $131 seen in December ...

Heart valve disease (HVD) is a leading cause of death in Scotland - affecting 73,000 people – but many have the condition ...

Edwards Lifesciences is transitioning, focusing on its cardiovascular business after divesting its Critical Care segment. See ...

Dr Stefania Angela Di Fusco and Professor Furio Colivicchi share the key themes, highlights and guidelines from ESC Congress ...